DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Zypitamag is a drug marketed by Medicure and is included in one NDA. There is one patent protecting this drug.
This drug has two patent family members in two countries.
The generic ingredient in ZYPITAMAG is pitavastatin magnesium. There are fifteen drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pitavastatin magnesium profile page.
By analyzing the patents and regulatory protections it appears that the earliest date
for generic entry will be January 19, 2031. This may change due to patent challenges or generic licensing.
Indicators of Generic Entry
Summary for ZYPITAMAG
|Finished Product Suppliers / Packagers:||2|
|Raw Ingredient (Bulk) Api Vendors:||34|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for ZYPITAMAG|
|What excipients (inactive ingredients) are in ZYPITAMAG?||ZYPITAMAG excipients list|
|DailyMed Link:||ZYPITAMAG at DailyMed|
DrugPatentWatch® Estimated Generic Entry Opportunity Date for ZYPITAMAG
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for ZYPITAMAG
ZYPITAMAG is protected by one US patents.
Based on analysis by DrugPatentWatch, the earliest date for a generic version of ZYPITAMAG is ⤷ Sign up for a Free Trial.
This potential generic entry date is based on patent ⤷ Sign up for a Free Trial.
Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.
Patents protecting ZYPITAMAG
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Medicure||ZYPITAMAG||pitavastatin magnesium||TABLET;ORAL||208379-001||Jul 14, 2017||DISCN||Yes||No||⤷ Sign up for a Free Trial||⤷ Sign up for a Free Trial||Y||Y||⤷ Sign up for a Free Trial|
|Medicure||ZYPITAMAG||pitavastatin magnesium||TABLET;ORAL||208379-002||Jul 14, 2017||RX||Yes||No||⤷ Sign up for a Free Trial||⤷ Sign up for a Free Trial||Y||Y||⤷ Sign up for a Free Trial|
|Medicure||ZYPITAMAG||pitavastatin magnesium||TABLET;ORAL||208379-003||Jul 14, 2017||RX||Yes||Yes||⤷ Sign up for a Free Trial||⤷ Sign up for a Free Trial||Y||Y||⤷ Sign up for a Free Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|